Intracellular Stability of TiO2-DNA Nanocomposites in Breast and Prostate Cancer Cells
Kenneth T. Thurn,Tatjana Paunesku,Eric Brown,Aiguo Wu,Benjamin Haley,Barry Lai,Stefan Vogt,J. Mäser,Gayle E. Woloschak
IF: 11.2
2007-01-01
Cancer Research
Abstract:1408 We have created an inducible titanium dioxide (TiO2)-DNA nanocomposite that is capable of sequence specific scission of nucleic acids, which we will attempt to use to target mutated oncogenes in malignant cells. TiO2-DNA nanocomposites consist of a 4.5 nm TiO2 nanoparticle covalently bound to a single stranded DNA using dopamine as a conductive linker. The nucleic acid maintains its ability to hybridize to complementary sequences[1]. Excitation of the nanoparticle with energies above 3.2 eV (white light, radiation) results in a charge separation in the nanoparticle. This causes electropositive holes to migrate through dopamine into the pi stack of the bound DNA resulting in cleavage of the nucleic acid [1]. By optimizing cleavage of the interstrand (target strand), we hope to be able to induce sequence specific scission of genomic DNA in living cells. Therefore we hypothesize that by targeting mutated genomic sequences specifically in malignant cells, it will be possible to knock out the oncogenes to which they have become “addicted.” The present experiments were aimed at characterizing the precise subcellular distribution and integrity of TiO2-DNA nanocomposites in prostate carcinoma PC3M and breast carcinoma MCF-7 cells. We have shown previously that localization of the nanocomposite depends on the presence of available complementary cellular DNA. Cells were transfected with nanocomposites whose DNA component was fluorescently labeled with tetramethylrhodamine(TAMRA) and was complementary to genomic DNA encoding 18S rRNA (ttccttggatgtggt) (where 200-300 copies are present in the nucleolus[2]). By visualizing the exact same cells by X-Ray induced X-Ray Fluorescence (XRF, performed at the 2-ID-D beamline at the Advanced Photon Source at Argonne National Laboratory) and fluorescent confocal microscopy, we are able to determine the intracellular stability of the nanocomposite. Since the titanium (nanoparticle) and TAMRA (DNA) distribution was virtually identical, it suggests that the nanocomposite is intact within living cells at 24 and 72 hours. Other experiments show for the first time that by coating the nanoparticle surface with Alizarin Red S, we are able to track the nanoparticle component directly with fluorescent confocal microscopy and flow cytometry. This has been verified with XRF. Therefore we conclude that (1) it is possible to independently track the DNA and TiO2 component within malignant cells using fluorescent confocal microscopy, and flow cytometry, (2) a significant amount of the nanocomposite remains intact in living cells for up to 72 hours. These results will allow future experiments to determine the precise mechanism by which the nanocomposites are internalized in order to optimize and characterize subcellular localization for oncogene targeting. [1] T. Paunesku, et. al. Nat. Mat., 2 :343,2002. [2] W. Makalowski, Acta Bioch. Pol., 48 (3):587,2001.